CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+20.26%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.43B
AUM Growth
+$2.43B
(+28%)
Cap. Flow
+$154M
Cap. Flow
% of AUM
6.32%
Top 10 Holdings %
Top 10 Hldgs %
66.61%
Holding
40
New
2
Increased
9
Reduced
8
Closed
9
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$120M |
| 2 |
GSK
GSK
|
$112M |
| 3 |
Tenet Healthcare
THC
|
$79.9M |
| 4 |
Biogen
BIIB
|
$49M |
| 5 |
Universal Health Services
UHS
|
$34.4M |
Top Sells
| 1 |
Cigna
CI
|
$42.4M |
| 2 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$41.3M |
| 3 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$37.3M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$30.4M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$19.5M |
Sector Composition
| 1 | Healthcare | 88.03% |
| 2 | Technology | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHNG
1
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $242M | 8.51% | 13,000,000 -2,000,000 | -13% | -$37.3M |
|
2
Viatris
VTRS
$12.3B
| $225M | 7.89% | 12,000,000 | – | – |
|
|
3
Universal Health Services
UHS
$11.6B
| $193M | 6.76% | 1,400,000 +250,000 | +22% | +$34.4M |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $184M | 6.44% | 1,175,000 -125,000 | -10% | -$19.5M |
|
5
HCA Healthcare
HCA
$94.5B
| $140M | 4.91% | 850,000 +125,000 | +17% | +$20.6M |
|
6
Alkermes
ALKS
$4.78B
| $135M | 4.73% | 6,750,000 -500,000 | -7% | -$9.98M |
|
7
Perrigo
PRGO
$3.27B
| $134M | 4.71% | 3,000,000 +150,000 | +5% | +$6.71M |
|
|
8
GSK
GSK
$79.9B
| $129M | 4.52% | 3,500,000 +3,050,000 | +678% | +$112M |
|
|
9
Tenet Healthcare
THC
$16.3B
| $120M | 4.2% | 3,000,000 +2,000,000 | +200% | +$79.9M |
|
|
WBA
10
DELISTED
Walgreens Boots Alliance
WBA
| $120M | 4.2% | +3,000,000 | New | +$120M |
|
11
Myriad Genetics
MYGN
$593M
| $98.9M | 3.47% | 5,000,000 | – | – |
|
12
Bausch Health
BHC
$2.74B
| $88.4M | 3.1% | 4,250,000 -250,000 | -6% | -$5.2M |
|
13
Ironwood Pharmaceuticals
IRWD
$214M
| $85.4M | 3% | 7,500,000 +250,000 | +3% | +$2.85M |
|
14
Sarepta Therapeutics
SRPT
$1.78B
| $68.2M | 2.39% | 400,000 -25,000 | -6% | -$4.26M |
|
15
Brookdale Senior Living
BKD
$1.83B
| $54M | 1.9% | 12,200,000 -2,800,000 | -19% | -$12.4M |
|
|
16
Biogen
BIIB
$19.4B
| $49M | 1.72% | +200,000 | New | +$49M |
|
|
TECX
17
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $43.7M | 1.53% | 3,133,333 +1,333,333 | +74% | +$18.6M |
|
18
Teva Pharmaceuticals
TEVA
$21.1B
| $43.4M | 1.52% | 4,500,000 | – | – |
|
19
Nektar Therapeutics
NKTR
$568M
| $42.5M | 1.49% | 2,500,000 | – | – |
|
20
Collegium Pharmaceutical
COLL
$1.22B
| $40.1M | 1.41% | 2,000,000 | – | – |
|
21
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $38.2M | 1.34% | 2,200,000 | – | – |
|
|
RDUS
22
DELISTED
Radius Health, Inc.
RDUS
| $37.1M | 1.3% | 2,075,000 | – | – |
|
|
BLUE
23
DELISTED
bluebird bio
BLUE
| $34.6M | 1.21% | 800,000 -300,000 | -27% | -$13M |
|
24
OraSure Technologies
OSUR
$242M
| $34.4M | 1.21% | 3,250,000 +500,000 | +18% | +$5.29M |
|
25
Puma Biotechnology
PBYI
$254M
| $26.2M | 0.92% | 2,555,000 | – | – |
|